CMPI

Checkmate Pharmaceuticals, Inc. Common Stock
CMPI

Overview Fund Activity
Delisted

CMPI was delisted on the 27th of May, 2022.

Back to rankings

25 hedge funds and large institutions have $46.3M invested in Checkmate Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
-6
Holders Change %
-19.35%
% of All Funds
0.39%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
5
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.66M
2
Millennium Management
2
Millennium Management
New York
$31K
3
Federated Hermes
3
Federated Hermes
Pennsylvania
$87K
4
UBS Group
4
UBS Group
Switzerland
$4K
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$2.78M

Top Sellers

1
CCP
1
Clough Capital Partners
Massachusetts
$3.75M
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$0
3
E
3
Ergoteles
New York
$0
4
Ensign Peak Advisors
4
Ensign Peak Advisors
Utah
$268K
5
HF
5
HRT Financial
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
HF
26
HRT Financial
New York
– -$72K -18,298 Closed
Renaissance Technologies
27
Renaissance Technologies
New York
– -$42K -10,667 Closed
PNC Financial Services Group
28
PNC Financial Services Group
Pennsylvania
– -$20K -5,000 Closed
TRCT
29
Tower Research Capital (TRC)
New York
– -$6K -1,426 Closed
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
– -$1K -185 Closed
1
2